摘要
目的探讨miR-155在乳腺癌侵袭中的作用及其作为乳腺癌预后预测新指标的可能性。方法88例乳腺癌患者于2002年3月至2005年12月接受改良根治术,随访资料完整。采用real—timePCR对原发肿瘤蜡块进行miR-155表达水平的测定,配对t检验比较癌组织和癌旁正常组织中miR-155的水平差异,MannWhitney—U非参数检验比较miR-155表达水平和乳腺癌临床病理参数的关系,预后分析采用Kaplan—Meier生存分析和Log—rank检验,采用Cox回归进行单因素及多因素分析。结果相比癌旁正常组织,癌组织中miR.155表达明显上调(t=6.75,P=0.000),在淋巴结转移、肿瘤较大、分期晚、HER.2阳性及伴有脉管瘤栓的乳腺癌组织中miR-155表达水平较高(Z=-6.320~-2.041,P=0.000~0.041)。以中位值2-ACt:4.87为截断值,Kaplan—Meier生存分析表明,低miR-155表达者总生存率高于miR-155高表达者(X^2=6.396,P=0.011)。单因素及多因素分析显示,miR-155表达与总生存率相关(HR=1.58,95%CI:0.87~3.16,P=0.082)。结论miR-155与淋巴结转移、肿瘤大小及HER-2基因表达显著相关,可作为乳腺癌侵袭潜能的预测指标。
Objective To investigate the potential use of miR-155 as novel breast cancer biomarker. Methods There were 88 breast cancer patients underwent modified mastectomy and had detailed clinical follow-up information. Extracting RNA from the formalin-fixed paraffin embedded (FFPE) samples, miR-155 levels were quantified by real-time-PCR, miR-155 levels among clinico-pathological variables were accessed by Mann Whitney-U test. Overall survival curve was derived from Kaplan-Meier estimates and the curve was compared by Log-rank test. Cox regression analysis was used for multivariate analysis. All statistical tests were two-sided. Results Significantly higher miR-155 level was found in tumor tissue compared to paired normal tissue (t = 6. 75, P = 0. 000). A potential relationship between miR-155 levels and existing clinico-pathological parameters of breast cancer, such as menstrual status, tumor size, nodal involvement, stage of disease, hormone receptor status, HER-2 status, histological grade or tumor subtype was investigated. Up-regulated miR-155 level was observed in breast cancer with lymph node metastasis, pT3 + 4, advanced TNM stage, HER-2 positive and with vascular invasion ( Z = - 6. 320 to - 2. 041, P = 0. 000 to 0. 041 ). When considering 2 ^- △Ct, = 4. 87 ( median level) as cut-off value, patients with miR-155 up-regulation showed a positive association towards a shorter overall survival ( X^2 = 6. 396, P =0. 011). In Cox multivariate analysis, miR-155 expression on FFPE was shown an inverse trend for outcomes of breast cancer (HR = 1.58, 95% CI:0. 87-3. 16, P = 0. 082). Conclusions miR-155, as an oncomir, promotes lymph node involvement and vascular invasion and accompanies over-expressed HER-2 on breast cancer FFPE tissue. It suggests that miR-155 could predict the invasiveness.
出处
《中华外科杂志》
CAS
CSCD
北大核心
2012年第11期1011-1014,共4页
Chinese Journal of Surgery
基金
福建省教育厅基金资助项目(JA11120)
福建省自然资助项目科学基金资助项目(2006J0096)
关键词
乳腺肿瘤
肿瘤浸润
微RNAS
预后
Breast neoplasm
Neoplasm, invasiveness
microRNAs
Prognosis